Table 1 Numbers of tumor samples that have clinical information available regarding response-to-chemotherapy, for each cancer type (n.b., the total number of labeled tumor samples exceeds the total number of patients because some patients had multiple tumors)
From: Predicting chemotherapy response using a variational autoencoder approach
Cancer type | Total number of samples (labeled and unlabeled) | Number of labeled samples | Proportion of labeled samples | Class balance ratio (responding/progressive) |
|---|---|---|---|---|
Breast invasive carcinoma (BRCA) | 1217 | 394 | 0.324 | 8.61 |
Colon adenocarcinomas (COAD) | 512 | 117 | 0.229 | 1.72 |
Bladder carcinoma (BLCA) | 430 | 115 | 0.267 | 0.95 |
Pancreatic adenocarcinoma (PAAD) | 182 | 115 | 0.632 | 0.77 |
Sarcoma (SARC) | 265 | 65 | 0.245 | 0.82 |
Sum | 2606 | 806 |